Sleep Medicine
Conference Coverage
Estimated prevalence of OSA in the Americas stands at 170 million
The United States has the greatest burden of OSA in the Americas, with an estimated 54 million cases.
Conference Coverage
CPAP for infants with OSA is effective with high adherence
DALLAS - Despite the additional challenges associated with CPAP therapy in infants, such as smaller face size for mask fit...
Conference Coverage
Pediatric lung disease plus nighttime screen time impact sleep quality
DALLAS – Children with cystic fibrosis or asthma report sleep interruptions 1 or 2 nights a week caused by their symptoms.
Latest News
Periodic limb movements during sleep are common in patients with MS and fatigue
SEATTLE – Sleep apnea may not be the only comorbidity that causes fatigue in multiple sclerosis, and treating...
Conference Coverage
Age may influence choice of behavioral therapy to improve sleep in MS
SEATTLE – Few studies have examined the relationships between physical activity, sedentary behavior, and sleep...
From the Journals
Severe OSA increases cardiovascular risk after surgery
General anesthetics, sedatives, and postoperative analgesics are potent respiratory depressants that relax the upper airway dilator muscles and...
Sleep Strategies
The burgeoning role of sleep-related chronic hypoxia in long-term outcomes
Chronic hypoxemia is frequent in chronic lung diseases, such as COPD, but how it leads to increased mortality in severe COPD is unknown.
News
Insomnia meds get boxed warning from FDA
Although complex sleep behaviors, such as sleep walking, associated with these medications are rare, the consequences can be deadly.
Conference Coverage
Sleep, chronic pain, and OUD have a complex relationship
MILWAUKEE – It’s not that easy to make direct connections among poor sleep, pain, and opioid use, Dr. Patrick Finan said.
From the Journals
PAP may reduce mortality in patients with obesity and severe OSA
A population-based cohort study has implications for clinical practice, but its results require confirmation in future trials.